Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review.
Purpose: Epidemiological and logistical reasons are slowing the clinical validation of the molecular imaging biomarkers in the initial stages of neurocognitive disorders. We provide an updated systematic review of the recent advances (2017–2022), highlighting methodological shortcomings. Methods: St...
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 51; no. 7; pp. 1876 - 1891 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |